Table 1. Characteristics of the study participants.
| Status n (%) | |||||||
| Hepatocellular carcinomawithout cirrhosis | Hepatocellular carcinomawith cirrhosis | Cholangicarginoma | Chronic liver disease | Reference group | |||
| N | 50 | 34 | 36 | 56 | 133 | ||
| <40 | 5 (10) | 0 (0) | 1 (2.8) | 5 (8.9) | 5 (3.8) | ||
| Age, years | 40–49 | 14 (28) | 6 (17.6) | 6 (16.7) | 12 (21.4) | 28 (21) | |
| 50–59 | 18 (36) | 19 (55.9) | 13 (36.1) | 26 (46.5) | 51 (38.4) | ||
| ≥60 | 13 (26) | 9 (26.5) | 16 (44.4) | 13 (23.2) | 49 (36.8) | ||
| Sex | Men | 41 (82) | 26 (76.5) | 23 (63.9) | 34 (60.7) | 77 (57.9) | |
| Women | 9 (18) | 8 (23.5) | 13 (36.1) | 22 (39.3) | 56 (42.1) | ||
| Negative | 19 (38) | 16 (47) | 34 (94.4) | 27 (48.2) | 112 (84.2) | ||
| HBsAg | Positive | 31 (62) | 17 (50) | 1 (2.8) | 29 (51.8) | 19 (14.3) | |
| N/A | 0 (0) | 1 (3) | 1 (2.8) | 0 (0) | 2 (1.5) | ||
| OR [95% CI] § | 11.67 [4.99–21.3] | 12.32 [4.43–34.27] | 0.18 [0.02–1.04] | 9.64 [4.31–21.57] | 1.00 | ||
| Hepatitis C | Negative | 43 (86)* | 23 (67.7) | 34 (94.4) | 43 (76.8) | 133 (100) | |
| Positive | 7 (14)* | 11 (32.3) | 2 (5.6) | 13 (23.2) | 0 (0) | ||
§
OR for HBsAg positivity calculated in relation to the R group. * X2 test when compared HCC/no cirrhosis Vs HCC/cirrhosis (p value = 0.044).